Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 50 entries
View as:

Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral Eczema

Phase: N/A Priority: Normal
NCT ID: NCT05540496 Org: User:
Start: 01/11/21 End: 04/17/21 Due: 04/17/22

Photoprotection Efficacy of a Sunscreen Under Visible Light Exposure by Using Two Different Simulators

Phase: N/A Priority: Normal
NCT ID: NCT06796140 Org: User:
Start: 03/08/21 End: 04/09/21 Due: 04/09/22

Photoprotection Efficacy of Four Sunscreen Formulas Under Visible Light Exposure

Phase: N/A Priority: Normal
NCT ID: NCT06796010 Org: User:
Start: 10/21/19 End: 11/23/19 Due: 11/23/20

Photoprotection Efficacy of Different Topical Agents Under Visible Light Exposure

Phase: N/A Priority: Normal
NCT ID: NCT06796153 Org: User:
Start: 04/23/21 End: 06/18/21 Due: 06/18/22

Determine the Photoprotection Efficacy of Seven Sunscreen Products Under Visible Light Exposure.

Phase: N/A Priority: Normal
NCT ID: NCT06796179 Org: User:
Start: 09/03/21 End: 10/08/21 Due: 10/08/22

Evaluation of the Photoprotection Efficacy of Three Sunscreen Products Under Visible Light Exposure.

Phase: N/A Priority: Normal
NCT ID: NCT06796205 Org: User:
Start: 06/09/21 End: 07/16/21 Due: 07/16/22

Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of Aging

Phase: N/A Priority: Normal
NCT ID: NCT00974480 Org: User:
Start: 09/30/09 End: 07/31/10 Due: 07/31/11

Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

Phase: N/A Priority: Normal
NCT ID: NCT06268496 Org: User:
Start: 03/14/24 End: 07/31/24 Due: 07/31/25

Efficacy and Tolerability of the Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins

Phase: N/A Priority: Normal
NCT ID: NCT06234527 Org: User:
Start: 02/29/24 End: 08/31/24 Due: 08/31/25

Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss

Phase: N/A Priority: Normal
NCT ID: NCT06590779 Org: User:
Start: 11/02/24 End: 05/02/26 Due: 05/02/27

Evaluation of Efficacy of Anthelios Sunscreen on Face Versus Usual Routine on Signs of Aging

Phase: N/A Priority: Normal
NCT ID: NCT06697288 Org: User:
Start: 04/03/24 End: 08/31/25 Due: 08/31/26

A Combination Treatment Reduces Acne Severity and PIHP

Phase: N/A Priority: Normal
NCT ID: NCT05601960 Org: User:
Start: 04/15/20 End: 02/28/21 Due: 02/28/22

Clinical Efficacy Evaluation of a Skincare Product for Acne Face, Upper Chest and Back Used by Multiphototype Population Under Dermatological Control

Phase: N/A Priority: Normal
NCT ID: NCT06786442 Org: User:
Start: 11/01/23 End: 01/26/24 Due: 01/26/25

Evaluate the Photoprotection Efficiency of Sunscreen Formulas Under Visible Light Exposure

Phase: N/A Priority: Normal
NCT ID: NCT06796088 Org: User:
Start: 09/23/20 End: 10/29/20 Due: 10/29/21

Effectiveness and Tolerance of Effaclar Serum in Women With Mandibular Acne

Phase: N/A Priority: Normal
NCT ID: NCT05457621 Org: User:
Start: 01/21/21 End: 07/08/21 Due: 07/08/22

Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma

Phase: N/A Priority: Normal
NCT ID: NCT06278948 Org: User:
Start: 10/06/23 End: 06/30/24 Due: 06/30/25

Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

Phase: N/A Priority: Normal
NCT ID: NCT06253455 Org: User:
Start: 11/13/23 End: 03/05/24 Due: 03/05/25

Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05531188 Org: User:
Start: 03/01/21 End: 11/03/21 Due: 11/03/22

UVA Protection Factors of SPF 50 and 50+ Face Sunscreens

Phase: N/A Priority: Normal
NCT ID: NCT06068010 Org: User:
Start: 04/20/18 End: 12/15/20 Due: 12/15/21

Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06274320 Org: User:
Start: 04/05/24 End: 06/30/25 Due: 06/30/26

Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00931411 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10

Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma

Phase: N/A Priority: Normal
NCT ID: NCT06516224 Org: User:
Start: 07/15/24 End: 01/31/25 Due: 01/31/26

Normaderm Phytosolution Global Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT05483205 Org: User:
Start: 07/01/19 End: 06/30/20 Due: 06/30/21

Effectiveness and Tolerance of Cicaplast Baume B5 After Superficial CO2 Laser Resurfacing

Phase: N/A Priority: Normal
NCT ID: NCT06467032 Org: User:
Start: 01/16/23 End: 04/21/23 Due: 04/21/24

A Scalp Lotion Toimprove Sensitive Scalp Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05630027 Org: User:
Start: 01/02/19 End: 06/30/20 Due: 06/30/21